Skip to main content
Clinical Trials/NCT06654362
NCT06654362
Completed
Not Applicable

The Effect of Multimodal Nutrition Intervention on Glucose and Lipid Parameters of Arfa Iron and Steel Company Workers

Peyman Sarsangi1 site in 1 country1,097 target enrollmentSeptember 23, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Blood Sugar
Sponsor
Peyman Sarsangi
Enrollment
1097
Locations
1
Primary Endpoint
Total Cholesterol, mg/dL
Status
Completed
Last Updated
last year

Overview

Brief Summary

The goal of this clinical trial is to investigate the impact of nutritional interventions on glycemic and lipid profile factors among workers.

The main questions it aims to answer are:

Does nutritional interventions (include: nutritional education and Change in the Factory Restaurant's Menu improve glycemic and lipid profile factors among workers? Researchers will compare glycemic and lipid profile factors among workers before and after nutritional intervention .

Registry
clinicaltrials.gov
Start Date
September 23, 2023
End Date
May 20, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Peyman Sarsangi
Responsible Party
Sponsor Investigator
Principal Investigator

Peyman Sarsangi

Mr. Peyman Sarasangi, [Principal Investigator]

Shahid Sadoughi University of Medical Sciences and Health Services

Eligibility Criteria

Inclusion Criteria

  • be Arfa's company worker

Exclusion Criteria

  • individuals who were diagnosed with any type of cancer

Outcomes

Primary Outcomes

Total Cholesterol, mg/dL

Time Frame: From enrollment to the end of intervention at 6 months

Total triglycerides, mg/dL

Time Frame: From enrollment to the end of intervention at 6 months

Low-density lipoprotein, mg/dL

Time Frame: From enrollment to the end of intervention at 6 months

High-density lipoprotein, mg/dl

Time Frame: From enrollment to the end of intervention at 6 months

Fast blood sugar, mg/dL

Time Frame: From enrollment to the end of intervention at 6 months

serum glutamic oxaloacetic transaminase, IU/L

Time Frame: From enrollment to the end of intervention at 6 months

serum glutamic pyruvic transaminase, IU/L

Time Frame: From enrollment to the end of intervention at 6 months

Study Sites (1)

Loading locations...

Similar Trials